By sub‐retinal injection of AAV‐PE2 into rd12 mice that serve as a disease model for LCA, an average efficiency of 6.4% was achieved without unintended byproducts, leading to the restoration of visual functions in the mouse models [33]. This evidence concerns the gene RPE65 and Leber congenital amaurosis.